Stocks Health care NEOG
NASDAQ · Health careNeogen Corp (NEOG)
Neogen Corp brought in $884M of revenue over the twelve months to August 31, 2026, down 0.3% from a year earlier. It posted a net loss of $56.1M. Operating cash flow minus capital spending left $31.9M of free cash flow in fiscal 2026. At August 31, 2026 it held $172M in cash against $774.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 7, 2026.
Key facts about Neogen Corp
- Net worth
- Neogen Corp has a market value (market cap) of $2.6B at the latest share price, and shareholders' equity of $2.1B on its balance sheet at August 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2026 revenue was $870.4M (-2.7% year on year), with a net loss of $7.9M. Over the 12 months to August 31, 2026: revenue $884M, net loss $56.1M.
- Cash flow
- In fiscal 2026 operations brought in $83.2M of cash; after $51.3M of capital spending, free cash flow was $31.9M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 7, 2026 and covers the period to August 31, 2026. Open on SEC EDGAR
- Next earnings report
- Neogen Corp's next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Neogen Corp does
Neogen Corp is registered with the SEC under industry code SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Its shares trade on NASDAQ under the ticker NEOG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $870.4M | -$7.9M | -$0.04 | $31.9M |
| 2025 | $894.7M | -$1.1B | -$5.03 | -$46.4M |
| 2024 | $924.2M | -$9.4M | -$0.04 | -$76.1M |
| 2023 | $822.4M | -$22.9M | -$0.12 | -$24.7M |
| 2022 | $527.2M | $48.3M | $0.45 | $43.6M |
| 2021 | $468.5M | $60.9M | $0.57 | $54.4M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where NEOG ranks in Health care
Latest SEC filings
What Neogen Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Other event 8-K
- October 26, 2026
- October 20, 2026
- October 20, 2026
- October 7, 2026Quarterly report10-Q · period to August 31, 2026Neogen reported revenue growth and narrowing operating losses for the first quarter, though bottom-line results swung to a net loss due to the absence of prior year asset sale gains.Revenue rose 6.5% to $222.8M versus the same quarter last year; diluted EPS -$0.05 versus $0.17.
- October 7, 2026
- October 6, 2026Quarterly results8-KNeogen reported first-quarter revenue growth of 6.5% and raised its full-year financial guidance.
- September 28, 2026Additional proxy material DEFA14A
- August 21, 2026
- August 21, 2026Additional proxy material DEFA14A
What is NEOG worth? A DCF from its reported cash flow
Insider trades
What the people running Neogen Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $6K and sold $114.7K worth of shares in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| November 4, 2026 | Yarwood JeremyChief Scientific Officer | Sold | 9,051 | $114.7K |
| November 3, 2026 | Yarwood JeremyChief Scientific Officer | Exercised options | 16,207 | $191.6K |
| November 3, 2026 | Yarwood JeremyChief Scientific Officer | Shares withheld for tax | 7,156 | $84.6K |
| November 2, 2026 | Freels Joe BChief Commercial Officer | Received as pay | 6,345 | $75K |
| October 29, 2026 | Borel James CDirector | Exercised options | 1,776 | $21.7K |
| October 29, 2026 | Capello Jeffrey DDirector | Exercised options | 1,776 | $21.7K |
| October 29, 2026 | Green Ronald DDirector | Exercised options | 1,776 | $21.7K |
| October 29, 2026 | Gupta AashimaDirector | Exercised options | 1,776 | $21.7K |
Who owns NEOG
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Neuberger Berman Group LLC13G, passive with 1 related filers | 7.6% | July 7, 2026 |
| Vanguard Portfolio Management13G, passive | 5.93% | April 29, 2026 |
| Vanguard Capital Management13G, passive | 5.13% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 316 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 33,431,015 | +810,010 |
| Neuberger Berman Group LLC | 16,570,795 | +8,819,077 |
| Vanguard Portfolio Management LLC | 13,038,732 | +206,468 |
| Dimensional Fund Advisors LP | 9,828,174 | +696,153 |
| Vanguard Capital Management LLC | 9,655,248 | +90,202 |
| Ing Groep NV | 9,102,300 | +198,000 |
| State Street Corp | 8,946,377 | +356,033 |
| Gates Capital Management, Inc. | 8,742,274 | +2,483,625 |
| Hudson Bay Capital Management LP | 6,500,000 | -180 |
| Geode Capital Management, LLC | 5,832,899 | +271,286 |
| Bamco Inc | 5,015,968 | +6,309 |
| Morgan Stanley | 4,306,091 | -274,336 |
| Mizuho Markets Americas LLC | 4,250,000 | +750,000 |
| National Bank of Canada | 4,000,000 | +500,000 |
| CIBC Bancorp USA Inc. | 3,549,006 | -2,444,216 |
| Cibc World Market Inc. | 3,500,500 | -2,461,100 |
| Healthcare of Ontario Pension Plan Trust Fund | 3,488,246 | +190,900 |
| MUFG Securities EMEA plc | 3,320,011 | -680,000 |
| SG Capital Management LLC | 3,319,145 | +1,182,421 |
| Ameriprise Financial Inc | 3,264,965 | +1,042,189 |
Insiders
17 insiders reported holding 1,117,673 shares in total, about $13.1M at the last price.
| Holder | Shares |
|---|---|
| Borel James CDirector | 212,888 |
| Nassif MikhealCEO, Director | 169,4972,211 held indirectly |
| Naemura David H.Former CFO | 90,388 |
| Capello Jeffrey DDirector | 85,198 |
| Rocklin Amy MFormer Chief Legal Officer | 82,182 |
| Gupta AashimaDirector | 75,774 |
| Rodriguez Rafael ADirector | 61,836 |
| Woteki Catherine EDirector | 58,428 |
| Green Ronald DDirector | 57,502 |
| Riggsbee Richard BryanCFO | 51,502 |
Questions about NEOG
What does Neogen Corp do?
Neogen Corp is a company in the Health care sector, listed on NASDAQ as NEOG. Its shares trade on NASDAQ under the ticker NEOG.
What is Neogen Corp's net worth?
Neogen Corp has a market value (market cap) of $2.6B at the latest share price, and shareholders' equity of $2.1B on its balance sheet at August 31, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Neogen Corp profitable?
No. Over the twelve months to August 31, 2026 it reported a net loss of $56.1M on revenue of $884M.
How much revenue does Neogen Corp make?
Over the twelve months to August 31, 2026 Neogen Corp reported revenue of $884M. That is 0.3% less than a year earlier.
When did Neogen Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 7, 2026. It covers the period to August 31, 2026. Its newest filing of any kind is the other event from November 4, 2026.
When is Neogen Corp's next earnings report?
Neogen Corp's next report is expected around January 7, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare NEOG with
Follow NEOG
Get an email when Neogen Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Neogen Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.